We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Simple Blood Test Identifies Organs Likely to Fail First

By LabMedica International staff writers
Posted on 07 Dec 2023
Print article
Image: A new study has found a way to predict which of our organs will fail first (Photo courtesy of illustratoren.de/TobiasWuestefeld)
Image: A new study has found a way to predict which of our organs will fail first (Photo courtesy of illustratoren.de/TobiasWuestefeld)

Similar to a typical car or house or society, the speed at which parts of the human body fall apart differs from part to part. In a groundbreaking study, researchers have developed a novel method to analyze organ aging by examining specific proteins or sets of proteins in the blood. This approach can predict an individual's risk for various diseases.

Investigators at Stanford Medicine (Stanford, CA, USA) conducted a study involving 5,678 participants that revealed organ age at varying rates. The research found that when an organ is significantly older than what is typical for a person's chronological age, that individual faces an increased risk for diseases related to that organ, as well as a higher mortality risk. The study found that approximately 20% of healthy adults over 50 have at least one organ aging much faster than normal. This finding suggests that a simple blood test could identify which organs in a person are aging rapidly, potentially allowing for early intervention before symptoms appear. Previous studies have generated single numbers to represent biological age, contrasting with chronological age. However, this new research assigns specific aging numbers to 11 key organs and systems: the heart, fat, lung, immune system, kidney, liver, muscle, pancreas, brain, vasculature, and intestine.

The researchers utilized available technologies and a unique algorithm to measure thousands of blood proteins, identifying nearly 1,000 proteins linked to specific organs. Abnormal protein levels were associated with accelerated aging of corresponding organs, increasing susceptibility to disease and death. They calculated an "age gap" for each organ, representing the difference between its actual and algorithm-predicted age. The study found significant associations between these age gaps and future mortality risk over 15 years, except for the intestine. An accelerated-aging organ, defined as having a biological age one standard deviation higher than the average for that organ in people of the same chronological age, was associated with a 15% to 50% increased mortality risk over the following 15 years.

The study also found that accelerated heart aging significantly increased the risk of heart failure, while older brains correlated with a higher likelihood of cognitive decline. Accelerated aging in the brain or vasculature was a strong predictor of Alzheimer’s disease progression. Additionally, there were clear connections between extremely aged kidneys and conditions like hypertension and diabetes, as well as between aged hearts and atrial fibrillation or heart attacks. The identification of organ-specific proteins that indicate excessive aging could also lead to new therapeutic targets, paving the way for drug development and more personalized medical interventions.

“We can estimate the biological age of an organ in an apparently healthy person,” said the study’s senior author, Tony Wyss-Coray, PhD, a professor of neurology and the D. H. Chen Professor II. “That, in turn, predicts a person’s risk for disease related to that organ.”

Related Links:
Stanford Medicine

New
Platinum Member
Flu SARS-CoV-2 Combo Test
OSOM® Flu SARS-CoV-2 Combo Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Liquid Ready-To-Use Lp(a) Reagent
Lipoprotein (a) Reagent

Print article
77 ELEKTRONIKA

Channels

Clinical Chemistry

view channel
Image: PhD student and first author Tarek Eissa has analyzed thousands of molecular fingerprints (Photo courtesy of Thorsten Naeser / MPQ / Attoworld)

Screening Tool Detects Multiple Health Conditions from Single Blood Drop

Infrared spectroscopy, a method using infrared light to study the molecular composition of substances, has been a foundational tool in chemistry for decades, functioning similarly to a molecular fingerprinting... Read more

Hematology

view channel
Image: The Truvian diagnostic platform combines clinical chemistry, immunoassay and hematology testing in a single run (Photo courtesy of Truvian Health)

Automated Benchtop System to Bring Blood Testing To Anyone, Anywhere

Almost all medical decisions are dependent upon laboratory test results, which are essential for disease prevention and the management of chronic illnesses. However, routine blood testing remains limited worldwide.... Read more

Immunology

view channel
Image: The blood test measures lymphocytes  to guide the use of multiple myeloma immunotherapy (Photo courtesy of 123RF)

Simple Blood Test Identifies Multiple Myeloma Patients Likely to Benefit from CAR-T Immunotherapy

Multiple myeloma, a type of blood cancer originating from plasma cells in the bone marrow, sees almost all patients experiencing a relapse at some stage. This means that the cancer returns even after initially... Read more

Microbiology

view channel
Image: Ultra-Rapid Antimicrobial Susceptibility Testing (uRAST) revolutionizing traditional antibiotic susceptibility testing (Photo courtesy of Seoul National University)

Ultra-Rapid Culture-Free Sepsis Test Reduces Testing Time from Days to Hours

Sepsis, a critical emergency condition, results from an overactive inflammatory response to pathogens like bacteria or fungi in the blood, leading to organ damage and the possibility of sudden death.... Read more

Pathology

view channel
Image: The AI model can distinguish different stages of DCIS from inexpensive and readily available breast tissue images (Photo courtesy of David A. Litman/Shutterstock)

AI Model Identifies Breast Tumor Stages Likely To Progress to Invasive Cancer

Ductal carcinoma in situ (DCIS) is a non-invasive type of tumor that can sometimes progress to a more lethal form of breast cancer and represents about 25% of all breast cancer cases. Between 30% and 50%... Read more

Industry

view channel
Image: Beckman Coulter will utilize the ALZpath pTau217 antibody to detect key biomarker for Alzheimer\'s disease on its DxI 9000 immunoassay analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter Licenses Alzpath's Proprietary P-tau 217 Antibody to Develop Alzheimer's Blood Test

Cognitive assessments have traditionally been the primary method for diagnosing Alzheimer’s disease, but this approach has its limitations as symptoms become apparent only after significant brain changes... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.